medigraphic.com
ISSN 0035-0052 (Impreso)

2003, Número 3

<< Anterior Siguiente >>

Rev Mex Pediatr 2003; 70 (3)


El Ureaplasma urealyticum en la enfermedad pulmonar crónica de neonatos pretérmino

Rivera TJA, Santellan OMR, Vega BM

Idioma: Español
Referencias bibliográficas: 42
Paginas: 146-150
Archivo PDF: 59.43 Kb.


RESUMEN

Varios estudios han documentado la transmisión vertical perinatal de Ureaplasma urealyticum en neonatos pretérmino, además se ha identificado en infantes nacidos muertos y recién nacidos con neumonía. Aunque aún no se aclara su mecanismo de patogenicidad hay cierto consenso de que esta bacteria tiene, de alguna manera, la capacidad de participar en la enfermedad pulmonar crónica de los recién nacidos. La prueba de PCR (reacción en cadena de la polimerasa) ha sido de gran utilidad en la detección temprana de este germen en secreciones respiratorias de neonatos. Otros estudios han valorado sus patrones de sensibilidad y resistencia a los antibióticos, facilitando la elección del antibiótico para el tratamiento de los neonatos con la enfermedad pulmonar.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Tully JG. Current status of the Mollicutes flora of humans. Clin Infect Dis 1993; 17(Suppl. 1): S2-S9.

  2. Gusman BS, Nepomniashchaia EM. Possible teratogenic effect of micoplasmas on the human fetus. Arkh Patol 1979; 41: 22-7.

  3. Shurin PA, Alpert S, Bernard RBA, Driscoll SG, Lee YII. Chorioamnionitis and colonization of the newborn infant with genital mycoplasmas. N Engl J Med 1975; 293: 5-8.

  4. Kundsin RB, Driscoll SC, Pelletier PA. Ureaplasma urealyticum incriminated in perinatal morbidity and mortality. Science 1981; 213: 474-5.

  5. Cassell GH, Waites KB, Watson HL, Crouse DT, Harasawa R. Ureaplasma urealyticum intrauterine infection: role in prematurity and disease in newborns. Clin Microbiol Rev 1993; 6: 69-87.

  6. Quinn PA. Mycoplasma infection of the fetus and newborns. Prog Clin Biol Res 1988; 281:107-51.

  7. Wang EEL, Cassell GH, Sanchez PJ, Regan JA, Payne NR, Liv PP. Ureaplasma urealyticum and chronic lung disease of prematurity: critical appraisal of the literature on causation. Clin Infect Dis 1993; 17(Suppl. 1): S112-S6.

  8. Hentschel J, Abele-Hom M, Peters J. Ureaplasma urealyticum in the cerebroespinal fluid of a premature infant. Acta Pediatr 1993; 82: 690-3.

  9. Heggie AD, Bar-Shain D, Boxerbaum B, Fanaroff AA, O’ Riordan MA, Robertson JA. Identification and quantification of Ureaplasma colonozing the respiratory tract and assessment of their role in the development of chronic lung disease in preterm infants. Pediatr Infect Dis J 2001; 20: 854-9.

  10. Ollikainen J, Korppi M, Heiskanen-Kosma T, Heinonen K. Chronic lung disease of the newborn in not associated with Ureaplasma urealyticum. Pediatr Pulmonol 2001; 32: 303-7.

  11. Galetto LA, Zamora S, Bertrand R, Brighi PL, Auckenthaler R, Berner M, Suter S. Colonization by Ureaplasma urealyticum and chronic lung disease in premature newborn infants under 32 weeks of gestation. Arch Pediatr 2001; 8: 39-46.

  12. Ollikainen J. Perinatal Ureaplasma urealyticum infection increases the need for hospital treatment during the first year of life in preterm infants. Pediatr Pulmonol 2000; 30: 402-5.

  13. Agarwal P, Rajadurai VS, Pradeepkumar VK, Tan KW. Ureaplasma urealyticum and its association with chronic lung disease in Asian. J Pediatr Child Health 2000; 36: 487-90.

  14. Zotter H, Urlesberger B, Reiterer F, Dornbusch HJ, Sixi B, Muller W. Ureaplasma urealyticum pneumonia and isolation of U. urealyticum from endotracheal tube aspirates of preterm and full-term infants. Gynakol Geburtshilfliche Rundsch 1999; 39: 191-4.

  15. Sethi S, Sharma M, Narang A, Aggrawal PB. Isolation pattern and clinical outcome of genital mycoplasma in neonates from a tertiary care neonatal unit. J Trop Pediatr 1999; 45: 143-5.

  16. Bowman ED, Dharmalingan A, Fan WQ, Brown F, Garland SM. Impact of erythromycin on colonization of Ureaplasma urealyticum and the development of chronic lung disease in extremely low birth weight infants. Pediatr Infect Dis J 1998; 17: 615-20.

  17. Waites KB, Crouse DT, Cassell GH. Systemic neonatal infection due to Ureaplasma urealyticum. Clin Infect Dis 1993; 17(Suppl. 1): S131-S5.

  18. Kotecha S, Wilson L, Wangoo A, Silverman M, Shaw RJ. Increase in interleukin (IL)-1 beta and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity. Pediatr Res 1996; 40: 250-6.

  19. Tullus K, Noack GW, Burman LG, Nilsson R, Wretlind B, Brauner A. Elevated cytokine levels in tracheobronchial aspirate fluids from ventilator treated neonates with bronchopulmonary dysplasia. Eur J Pediatr 1996; 155: 112-6.

  20. Ozdemir A, Brown MA, Morgan WJ. Markers and mediators of inflammation in neonatal lung disease. Pediatr Pulmonol 1997; 23: 292-306.

  21. De Dooy JJ, Mahieu LM, Van Bever HP. The role of inflammation in the development of chronic lung disease in neonates. Eur J Pediatr 2001; 160: 457-63.

  22. Jonson B, Tullus K, Brauner A, Lu Y, Noack G. Early increase of TNF alpha and IL-6 in tracheobronchial aspirate fluid indicator of subsequent chronic lung disease in preterm infants. Arch Dis Child Fetal Neonatal Ed 1997; 77: F198-F201.

  23. Cassell GH, Waites KB, Crouse DT, Rudd PT, Canupp KC, Stagno S, Cutter GR. Association of Ureaplasma urealyticum infection of the lower respiratory tract with chronic lung disease and death in very-low-bith-weigth infants. Lancet 1988; 2: 240-5.

  24. Crouse DT, Odrezin GT, Cutter GR, Reese JM, Hamrick WB, Waites KB, Cassell GH. Radiographic changes associated with tracheal isolation of Ureaplasma urealyticum from neonates. Clin Infect Dis 1993; 17(Suppl. 1): S122-S30.

  25. Abele-Horn M, Peters J, Genzel-Boroviczeny O, Wolff C, Zimmermann A, Gottschling W. Vaginal Ureaplasma urealyticum colonization: influence on pregnancy outcome and neonatal morbidity. Infection 1997; 25: 286-91.

  26. Walsh WF, Butler J, Coalson J, Hensley D, Cassell GH, deLemos RA. A primate model of Ureaplasma urealyticum infection in the premature infants with hyaline membrane disease. Clin Infect Dis 1993; 17(Suppl. 1): S158-S62.

  27. Rudd PT, Cassell GH, Waites KB, Davis JK, Duffy LB. Ureaplasma urealyticum pneumonia: experimental production and demonstration of age-related susceptibility. Infect Immun 1989; 57: 918-25.

  28. Li YH, Brauner A, Jonsson B, Van Der PI, Soder O, Holst M, Skov JJ, Lagercrantz H, Tullus K. Ureaplasma urealyticum-induced production of proinflammatory cytokines by macrophages. Pediatr Res 2000; 48: 114-9.

  29. De Silva NS, Quinn PA. Endogenous activity of phospholipase A and C in Ureaplasma urealyticum. J Clin Microbiol 1986; 23: 354-9.

  30. Baldie G, Kaimakamis D, Rotondo D. Fatty acid modulation of cytokine release from human monocytic cells. Biochim Biophys Acta 1993; 1179: 125-33.

  31. Holladay CS, Wright RM, Spangelo BL. Arachidonic acid stimulates interleukin-6 release from rat peritoneal macrophages in vitro: evidence for a prostacyclin-dependent mechanism. Prostaglandins Leukot Essent Fatty Acids 1993; 49: 915-22.

  32. Castro AS, Greenberg ME, Bateman AD, Regan AJ. Patterns of colonization with Ureaplasma urealyticum during neonatal intensive care unit hospitalizations of very low birth weight infants and the development of chronic lung disease. Pediatrics 2002; 110: 1-7. 33. Perzigian RW, Adams JT, Weiner GM, Dipietro MA, Blythe LK, Pierson CL, Faix RG. Ureaplasma urealyticum and chronic lung disease in very low bith weight infants during the exogenous surfactant era. Pediatr Infect Dis 1998; 17: 620-5.

  33. Pierce MR, Bancalari E. The role of inflammation in the pathogenesis of bronchopulmonary dysplasia. Pediatr Pulmonol 1995; 19: 371-8.

  34. Bancalari E. Corticoesteroids and neonatal chronic lung disease. Eur J Pediatr 1998; 157: 31-7.

  35. Naessens A, Foulon W, Breynaert J, Lauwers S. Serotypes of Ureaplasma urealyticum isolated from normal pregnant women and patients with pregnancy complications. J Clin Microbiol 1988; 26: 319-22.

  36. Quinn PA, Rubin S, Nocilla DM, Read SE, Chipman M. Serological evidence of Ureaplasma urealyticum infection in neonatal respiratory disease. Yale J Biol Med 1983; 56: 565-72.

  37. Luki N, Lebel P, Boucher M, Doray B, Turgeon J, Brousseau R. Comparison of polymerase chain reaction assay with culture for detection of genital mycoplasmas in perinatal infections. Eur J Clin Microbiol Infect Dis 1998; 17: 255-63.

  38. Nelson S, Matlow A, Johnson G, Dunn M, Quinn P. Detection of Ureaplasma urealyticum in endotracheal tube aspirate from neonates by PCR. J Clin Microbiol 2000; 36: 1236-9.

  39. Persing DH. Polymerase chain reaction: trenches to benches. J Clin Microbiol 1991; 29: 1281-5.

  40. Blanchard A, Hentschel J, Duffy L, Baldus K, Cassell GH. Detection of Ureaplasma urealyticum by polimerase chain reaction in the urogenital tract of adults, in amniotic fluid, and in the respiratory tract of newborns. Clin Infect Dis 1993; 17(Suppl. 1): S148-S53.

  41. Waites KB, Crouse DT, Cassell GH. Antibiotic susceptibilities and therapeutic options for Ureaplasma urealyticum infections in neonates. Pediatr Infect Dis 1992; 11: 23-9.

  42. Kenny EG, Cartwright DF. Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines, and quinolones. Antimicrob Agents Chemother 2001; 45: 2604-8.




2020     |     www.medigraphic.com